News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeoPharm (NEOL) Says Japan's Nippon Kayaku Co., Ltd. Terminates License Agreement


9/14/2007 8:08:14 AM

Sept 14 (Reuters) - Drug developer NeoPharm Inc. (NEOL.O: Quote, Profile, Research) said Japanese company Nippon Kayaku Co Ltd (4272.T: Quote, Profile, Research) terminated a license agreement to develop NeoPharm's brain cancer drug in Japan, after U.S. health regulators requested for an additional trial.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES